Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04223934
NA

Tailored Drug Titration Using Artificial Intelligence

Sponsor: Optima Integrated Health

View on ClinicalTrials.gov

Summary

The purpose of the ARTERY Outcomes study is to compare optima-for-blood pressure (optima4BP), a clinical decision support system for hypertension (HTN) treatment optimization to standard of care in patients with essential HTN.

Official title: ARTERY Outcomes: Tailored Drug Titration Through Artificial Intelligence - an Interventional Study

Key Details

Gender

All

Age Range

21 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

165

Start Date

2020-02-18

Completion Date

2023-06-27

Last Updated

2026-07-20

Healthy Volunteers

No

Conditions

Interventions

OTHER

optima4BP

optima4BP establishes a "no gaps" computational framework in determining the most effective treatment change that can optimize a patient's HTN management towards BP Target. All possible drug combination options available through the 16 anti-HTN drug classes and subclasses are quantitatively evaluated in the context of 5 actions: add a drug, remove a drug, replace a drug, increase a drug dose, and decrease a drug dose. The pharmacological intervention efficacy ranking is computed and the highest ranked treatment recommendation is selected for consideration by the treating physician.

Locations (1)

University of California San Francisco

San Francisco, California, United States